Asentar news from FierceBiotech
NewsNovacea cuts staff after partner dumps collaboration
A month after Schering-Plough pulled the plug on its collaboration with Novacea for a new prostate cancer therapy--Read more...
| Press ReleasesPRESS RELEASE: Novacea Halts Late-Stage Trial of Prostate Cancer Drug Asentar Novacea Halts Late-Stage Trial of Prostate Cancer Drug Asentar SOUTH SAN FRANCISCO, CA - Nov 5, 2007 -- Novacea announced today that the company has ended its Phase 3 ASCENT-2 clinical trial of Read more... |
Paid Research Reports
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
- The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends